John Sterling
Editor-in-Chief at Genetic Engineering & Biotechnology News
Editor in Chief of Genetic Engineering & Biotechnology News (GEN) since 1985; BS degree in biology from CCNY and MA in journalism from Univ of Minnesota
Articles
-
6 days ago |
genengnews.com | John Sterling
Home Topics Bioprocessing WuXi Biologics Reports Completion of First Commercial PPQ Campaign at 15,000 L... Credit: WuXi Biologics Credit: WuXi Biologics WuXi Biologics completed the first commercial project Process Performance Qualification (PPQ) campaign for its three sets of 5,000 L single-use bioreactors (SUBs) in the second drug substance line of its MFG20 facility at the Hangzhou site in China.
-
1 week ago |
genengnews.com | John Sterling
Home Topics Bioprocessing Cyprumed and MSD Agree to Develop Oral Peptide Formulations and CDMO Meribel... Credit: Sean Anthony Eddy/Getty Images Credit: Sean Anthony Eddy/Getty Images Cyprumed and MSD signed a nonexclusive license and option agreement to develop oral formulations of MSD’s peptides using Cyprumed’s innovative drug delivery technology. MSD gains nonexclusive global rights to Cyprumed’s oral peptide delivery platform for an undisclosed number of targets.
-
1 week ago |
genengnews.com | John Sterling
Home Topics Genome Editing Dire Wolves? Gray Wolves? What Kind of Wolf Am I? Three-month-old wolf pups, Romulus and Remus. [Colossal Biosciences] Three-month-old wolf pups, Romulus and Remus. [Colossal Biosciences] “You’re hearing the first howl of a dire wolf in over 10,000 years.
-
2 weeks ago |
genengnews.com | John Sterling
Cellares agreed to collaborate with the University of Wisconsin School of Medicine and Public Health to automate the manufacturing of a CRISPR-edited GD2 CAR-T investigational therapy. Company officials say their Cell ShuttleTM supports early-phase biotechnology and academic cell therapy developers by providing an integrated, automated solution enabling economies of scale.
-
2 weeks ago |
genengnews.com | John Sterling |Gail Dutton
Human pluripotent stem cells (hPSCs) typically take between 9 and 15 days to differentiate into vascular endothelial cells. At their most productive, only about 60% actually differentiate. A new method reduces that time to only five days, delivers 99% differentiation, and, according to the researchers, is easy and scalable.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 274
- Tweets
- 31
- DMs Open
- No
Genetic Engineering & Biotechnology News (GEN) is looking for researchers and science students interested in exploring science writing as interns putting together short daily news stories. For details, contact John Sterling, Editor in Chief, at [email protected]
.@GENbio is looking for biotech, science, and pharma freelance writers in the US, Europe, Asia, and So America. Background in science essential and 1-2 years writing exp required. Email resume & writing samples to [email protected]
BIG #BlackInGenetics is an organization dedicated to amplifying the voices and work of Black-identifying geneticists across the U.S. and beyond. This is #Blackingeneticsweek.@GENbio